Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors

Myeloid-derived suppressor cells (MDSCs) are known to promote tumor growth in part by their immunosuppressive activities and their angiogenesis support. It has been shown that Bv8 blockade inhibits the recruitment of MDSCs to tumors, thereby delaying tumor relapse associated with resistance to antia...

Descripción completa

Detalles Bibliográficos
Autores principales: Benguigui, Madeleine, Vorontsova, Avital, Timaner, Michael, Levin, Sapir, Haj-Shomaly, Jozafina, Deo, Abhilash, Menachem, Rotem, Manobla, Bar, Cooper, Tim J., Raviv, Ziv, Shaked, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301046/
https://www.ncbi.nlm.nih.gov/pubmed/35874722
http://dx.doi.org/10.3389/fimmu.2022.903591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301046/
https://www.ncbi.nlm.nih.gov/pubmed/35874722
http://dx.doi.org/10.3389/fimmu.2022.903591

Ejemplares similares